論文・総説 - 末永　光邦

分割表示  324 件中 101 - 120 件目  ／  全件表示 >>

  1. Berger Martin D., Stintzing Sebastian, Yang Dongyun, Suenaga Mitsukuni, Miyamoto Yuji, Cao Shu, Soni Shivani, Gopez Roel, Hanna Diana L., Zhang Wu, Heinemann Volker, Lenz Heinz-Josef. Effect of polymorphisms of genes encoding regulatory proteins in the coagulation cascade on outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  2. Takahari Daisuke, Wakatsuki Takeru, Mashima Tetsuo, Ichimura Takashi, Chin Keisho, Ogura Mariko, Nakayama Izuma, Matsushima Tomohiro, Osumi Hiroki, Ozaka Masato, Suenaga Mitsukuni, Shinozaki Eiji, Seimiya Hiroyuki, Fujita Naoya, Yamaguchi Kensei. Plasma biomarker analysis of ramucirumab in Japanese patients with advanced gastric cancer: Preliminary results. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  3. Suenaga Mitsukuni, Schirripa Marta, Cao Shu, Zhang Wu, Yang Dongyun, Marmorino Federica, Bergamo Francesca, Antoniotti Carlotta, Rossini Daniele, Ning Yan, Okazaki Satoshi, Berger Martin D., Miyamoto Yuji, Gopez Roel, Hanna Diana L., Barzi Afsaneh, Mashima Tetsuo, Yamaguchi Toshiharu, Loupakis Fotios, Lenz Heinz-Josef. Role of genetic polymorphisms in CCL5/CCR5 axis to predict efficacy of regorafenib in patients with refractory metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  4. Nagaoka Tomoyuki, Wakatsuki Takeru, Shinozaki Eiji, Nakayama Izuma, Suenaga Mitsukuni, Fukuda Naoki, Osumi Hiroki, Matsushima Tomohiro, Ichimura Takashi, Ogura Mariko, Ozaka Masato, Takahari Daisuke, Chin Keisho, Yamaguchi Kensei. Prognostic impact of primary tumor location in patients with metastatic colorectal cancer (mCRC) at the salvage lines. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  5. Miyamoto Yuji, Stintzing Sebastian, Zhang Wu, Cao Shu, Ning Yan, Okazaki Satoshi, Berger Martin D., Suenaga Mitsukuni, Schirripa Marta, Soni Shivani, Matsusaka Satoshi, Yang Dongyun, Gopez Roel, Hanna Diana L., Barzi Afsaneh, Baba Hideo, Heinemann Volker, Lenz Heinz-Josef. Polymorphisms in adipokine-related genes to predict treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab-based chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  6. Kawakami Kazuyoshi, Suenaga Mitsukuni, Soejima Azusa, Sugita Kazuo, Yokokawa Takashi, Suzuki Kenichi, Inoue Ayaka, Machida Yohiaki, Wakatsuki Takeru, Yamaguchi Kensei, Hama Toshihiro. Self-reported adherence to regorafenib for metastatic colorectal cancer: A retrospective cohort study. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  7. Nakayama Izuma, Shinozaki Eiji, Matsushima Tomohiro, Wakatsuki Takeru, Ogura Mariko, Ichimura Takashi, Ozaka Masato, Takahari Daisuke, Suenaga Mitsukuni, Chin Keisho, Mizunuma Nobuyuki, Yamaguchi Kensei. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients BMC CANCER. 2017.01; 17 (1): 38. ( PubMed, DOI )

  8. Kawakami Kazuyoshi, Yokokawa Takashi, Kobayashi Kazuo, Sugisaki Takahito, Suzuki Kenichi, Suenaga Mitsukuni, Yamaguchi Kensei, Inoue Ayaka, Machida Yoshiaki, Yamaguchi Toshiharu, Hama Toshihiro. Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer ONCOLOGY RESEARCH. 2017; 25 (9): 1625-1631. ( PubMed, DOI )

  9. Okazaki S., Loupakis F., Schirripa M., Cao S., Zhang W., Yang D., Ning Y., Berger M. D., Miyamoto Y., Suenaga M., Gopez R., Borelli B. B., Cremolini C., Falcone A., Lonardi S., Salvatore L., Uetake H., Kawano T., Helentjaris T., Lenz H-J.. Tandemrepeat variation in HIC1 gene predicts outcome for oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer ANNALS OF ONCOLOGY. 2016.10; 27 ( DOI )

  10. Berger Martin D., Yang Dongyun, Sunakawa Yu, Zhang Wu, Ning Yan, Matsusaka Satoshi, Okazaki Satoshi, Miyamoto Yuji, Suenaga Mitsukuni, Schirripa Marta, Lenz Annika Medea, Bohanes Pierre, Barzi Afsaneh, Figueiredo Jane C., Hanna Diana L., Lenz Heinz-Josef. Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012 ONCOTARGET. 2016.08; 7 (33): 53668-53678. ( PubMed, DOI )

  11. Osumi Hiroki, Shinozaki Eiji, Suenaga Mitsukuni, Matsusaka Satoshi, Konishi Tsuyoshi, Akiyoshi Takashi, Fujimoto Yoshiya, Nagayama Satoshi, Fukunaga Yosuke, Ueno Masashi, Mise Yoshihiro, Ishizawa Takeaki, Inoue Yosuke, Takahashi Yu, Saiura Akio, Uehara Hirohumi, Mun Mingyon, Okumura Sakae, Mizunuma Nobuyuki, Miki Yoshio, Yamaguchi Toshiharu. RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy INTERNATIONAL JOURNAL OF CANCER. 2016.08; 139 (4): 803-811. ( PubMed, DOI )

  12. Okazaki Satoshi, Loupakis Fotios, Stintzing Sebastian, Cao Shu, Zhang Wu, Yang Dongyun, Ning Yan, Sunakawa Yu, Stremitzer Stefan, Matsusaka Satoshi, Berger Martin D., Parekh Anish, West Jordan D., Miyamoto Yuji, Suenaga Mitsukuni, Schirripa Marta, Cremolini Chiara, Falcone Alfredo, Heinemann Volker, DePaolo R. William, Lenz Heinz-Josef. Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab MOLECULAR CANCER THERAPEUTICS. 2016.07; 15 (7): 1740-1745. ( PubMed, DOI )

  13. Osumi H., Shinozaki E., Suenaga M., Matsusaka S., Nakayama I., Wakatsuki T., Ogura M., Ozaka M., Takashi I., Takahari D., Chin K., Mizunuma N., Yamaguchi K.. Phase II study of biweekly cetuximab and irinotecan as third-line therapy in patients with pre-treated KRAS exon2 wild-type metastatic colorectal cancer ANNALS OF ONCOLOGY. 2016.06; 27 16.

  14. Suenaga Mitsukuni, Mashima Tetsuo, Kawata Naomi, Wakatsuki Takeru, Horiike Yuki, Matsusaka Satoshi, Dan Shingo, Shinozaki Eiji, Seimiya Hiroyuki, Mizunuma Nobuyuki, Yamaguchi Kensei, Yamaguchi Toshiharu. Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer ONCOTARGET. 2016.06; 7 (23): 34811-34823. ( PubMed, DOI )

  15. Matsusaka Satoshi, Ning Yan, Yang Dongyun, Zhang Wu, Hanna Diana L., Cao Shu, Suenaga Mitsukuni, Okazaki Satoshi, Berger Martin D., Lenz Heinz-Josef. Epidermal growth factor receptor mRNA expression in circulating tumor cells as a potential mechanism of molecular escape from regorafenib therapy. JOURNAL OF CLINICAL ONCOLOGY. 2016.05; 34 (15): ( DOI )

  16. Gopez Roel, Schirripa Marta, Zhang Wu, Cao Shu, Okazaki Satoshi, Yang Dongyun, Loupakis Fotios, Berger Martin D., Ning Yan, Miyamoto Yuji, Suenaga Mitsukuni, West Jordan David, Hanna Diana L., Barzi Afsaneh, Falcone Alfredo, Stintzing Sebastian, Heinemann Volker, Lenz Heinz-Josef. IRS1 and IRS2 polymorphisms and outcome in mCRC patients enrolled in the FIRE-3 trial. JOURNAL OF CLINICAL ONCOLOGY. 2016.05; 34 (15): ( DOI )

  17. Cao Shu, Yang Dongyun, Stintzing Sebastian, Loupakis Fotios, Zhang Wu, Ning Yan, Schirripa Marta, Suenaga Mitsukuni, Okazaki Satoshi, Miyamoto Yuji, Barzi Afsaneh, Lenz Heinz-Josef. Identifying predictive SNPs in patients with metastatic colorectal cancer (mCRC) using Random Survival Forests JOURNAL OF CLINICAL ONCOLOGY. 2016.05; 34 (15): ( DOI )

  18. Miyamoto Yuji, Stintzing Sebastian, Loupakis Fotios, Zhang Wu, Cao Shu, Ning Yan, Okazaki Satoshi, Berger Martin D., Suenaga Mitsukuni, Schirripa Marta, Matsusaka Satoshi, Yang Dongyun, West Jordan David, Gopez Roel, Hanna Diana L., Barzi Afsaneh, Baba Hideo, Heinemann Volker, Lenz Heinz-Josef. Genetic variations associated with cancer cachexia pathways to predict survival in metastatic colorectal cancer (mCRC): Results from FIRE-3 and TRIBE. JOURNAL OF CLINICAL ONCOLOGY. 2016.05; 34 (15): ( DOI )

  19. Ning Yan, Stintzing Sebastian, Zhang Wu, Yang Dongyun, Hanna Diana L., Okazaki Satoshi, Berger Martin D., Miyamoto Yuji, West Jordan David, Suenaga Mitsukuni, Schirripa Marta, Barzi Afsaneh, Heinemann Volker, Lenz Heinz-Josef. Genetic variants of R-spondin genes to predict clinical outcome in mCRC patients (pts) treated with first line FOLFIRI and bevacizumab (FOLFIRI/BEV) in FIRE-3 cohort. JOURNAL OF CLINICAL ONCOLOGY. 2016.05; 34 (15): ( DOI )

  20. Suenaga Mitsukuni, Schirripa Marta, Cao Shu, Zhang Wu, Yang Dongyun, Berger Martin D., West Jordan David, Cremolini Chiara, Lonardi Sara, Battaglin Francesca, Ning Yan, Horiike Yuki, Yamamoto Noriko, Okazaki Satoshi, Miyamoto Yuji, Hanna Diana L., Barzi Afsaneh, Loupakis Fotios, Falcone Alfredo, Lenz Heinz-Josef. Genetic variants of Pint to predict benefit from irinotecan and oxaliplatin based treatment in patients with metastatic colorectal cancer (mCRC). JOURNAL OF CLINICAL ONCOLOGY. 2016.05; 34 (15): ( DOI )

< 前のページ - 次のページ >

このページの先頭へ▲